LinkedIn post Isologic goes electric

🔌Isologic Goes Electric!

We are excited to announce the expansion of our electric fleet with the addition of the Mercedes-Benz eCitan. This compact and sustainable vehicle boasts a range of approximately 280km and can be rapidly charged from 20% to 80% ursing fast-charging stations. 

Our commitment to electric mobility is driven by our collaboration with Radboud Translational Medicine B.V., where we transport medical isotopes daily to healthcare facilities both domestically and internationally. Furthermore, many of our clients are increasingly seeking sustainable logistics solutions. With the implementation of zero-emission zones in cities such as Nijmegen, and the expectation that more cities will follow this example, this is a significant step forward.

At Isologic, delivery reliability is paramount: it is crucial that hospitals receive the necessary medical sources on time for patient treatment. The Mercedes-Benz eCitan supports us in this mission with its dependable performance and swift charging capabilities.

A notable feature of this eCitan is its specialized software that optimizes temperature settings for efficient charging. We will now rigorously test the performance and reliability of this electric van, as we previously did with an electric FIAT Doblo. Interested in the results? Please contact us: https://lnkd.in/et8ny4EK

#Isologic hashtag#ElectricDriving hashtag#Sustainability hashtag#Logistics hashtag#Healthcare hashtag#ZeroEmission

LinkedIn post Isologic goes electric

Other news

RTM receives marketing authorisation for Fludeoxyglucose (18F)

RTM receives marketing authorisation for Fludeoxyglucose (18F)

We are happy to announce that RTM has received marketing authorization for 18F-FDG of 17 July 2018....

Read more

Cooperation RTM-Alliance Medical

Cooperation RTM-Alliance Medical

It is with great pleasure that we announce our cooperation with Alliance Medical Group (AMG) regardi...

Read more

First Patient Dosed with TLX250-CDx in Italy for ccRCC

First Patient Dosed with TLX250-CDx in Italy for ccRCC

The below product is manufactured at RTM First Patient dosed with TLX250-CDx in Italy for ccRCC Th...

Read more

LinkedIn post ESRR2024

LinkedIn post ESRR2024

📢 Important update on EU #GMP Annex 1 at #ESRR2024!  The revised EU GMP Annex 1, effecti...

Read more

Interested in a collaboration?

Contact us to discuss the possibilities.